These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21652674)

  • 1. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models.
    Bertilaccio MT; Simonetti G; Dagklis A; Rocchi M; Rodriguez TV; Apollonio B; Mantovani A; Ponzoni M; Ghia P; Garlanda C; Caligaris-Cappio F; Muzio M
    Blood; 2011 Jul; 118(3):660-9. PubMed ID: 21652674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.
    Vilia MG; Fonte E; Veliz Rodriguez T; Tocchetti M; Ranghetti P; Scarfò L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Ghia P; Muzio M
    Leuk Lymphoma; 2017 Oct; 58(10):2419-2425. PubMed ID: 28278705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.
    Garlanda C; Anders HJ; Mantovani A
    Trends Immunol; 2009 Sep; 30(9):439-46. PubMed ID: 19699681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells.
    Lech M; Garlanda C; Mantovani A; Kirschning CJ; Schlöndorff D; Anders HJ
    Kidney Int; 2007 Jul; 72(2):182-92. PubMed ID: 17495864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
    Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
    Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
    Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
    Efanov A; Zanesi N; Nazaryan N; Santanam U; Palamarchuk A; Croce CM; Pekarsky Y
    Leukemia; 2010 May; 24(5):970-5. PubMed ID: 20357824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
    Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
    J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.
    Yan XJ; Albesiano E; Zanesi N; Yancopoulos S; Sawyer A; Romano E; Petlickovski A; Efremov DG; Croce CM; Chiorazzi N
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11713-8. PubMed ID: 16864779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
    Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
    Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model.
    Lascano V; Guadagnoli M; Schot JG; Luijks DM; Guikema JE; Cameron K; Hahne M; Pals S; Slinger E; Kipps TJ; van Oers MH; Eldering E; Medema JP; Kater AP
    Blood; 2013 Dec; 122(24):3960-3. PubMed ID: 24100449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
    DiLillo DJ; Weinberg JB; Yoshizaki A; Horikawa M; Bryant JM; Iwata Y; Matsushita T; Matta KM; Chen Y; Venturi GM; Russo G; Gockerman JP; Moore JO; Diehl LF; Volkheimer AD; Friedman DR; Lanasa MC; Hall RP; Tedder TF
    Leukemia; 2013 Jan; 27(1):170-82. PubMed ID: 22713648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
    Alhakeem SS; McKenna MK; Oben KZ; Noothi SK; Rivas JR; Hildebrandt GC; Fleischman RA; Rangnekar VM; Muthusamy N; Bondada S
    J Immunol; 2018 Jun; 200(12):4180-4189. PubMed ID: 29712773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is miR-29 an oncogene or tumor suppressor in CLL?
    Pekarsky Y; Croce CM
    Oncotarget; 2010 Jul; 1(3):224-7. PubMed ID: 20936047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
    Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
    J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of toll-like receptors in chronic B-cell malignancies.
    Muzio M; Bertilaccio MT; Simonetti G; Frenquelli M; Caligaris-Cappio F
    Leuk Lymphoma; 2009 Oct; 50(10):1573-80. PubMed ID: 19672768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
    Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
    Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.